Conference Coverage: ESMO 2023 – Focus on Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Global clinical experts discuss perspectives on current treatment strategies and emerging therapies in advanced SCCHN
October 31, 2023
FACULTY CHAIR
Amanda Psyrri, MD, PhD
Attikon University Hospital, Chaidari, Greece
Faculty Members
Christophe Le Tourneau, MD, PhD
Institut Curie, Paris, France
Ulrich Keilholz, MD, PhD
Charité Comprehensive Cancer Center, Berlin, Germany
Maura Gillison, MD, PhD
MD Anderson Cancer Center, Houston, TX, USA
Tanguy Seiwert , MD
Johns Hopkins School of Medicine, Baltimore, MD, USA
Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center, Pittsburgh, PA, USA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Early and Locally Advanced SCCHN – Current Treatment Strategies and Novel Therapeutic Approaches
- Metastatic SCCHN – Focus on Targeted Treatment Strategies
- Metastatic SCCHN – Focus on Immune Checkpoint Therapy Combinations (IO, BsAbs, and Vaccines)
- Metastatic SCCHN – Focus on Immune Checkpoint Therapy Combinations (Oncolytics, ADC, Others)
- SCCHN – Learnings From Real-World Data
